Managing Placebo Risk Under the Microscope: Science, Operations, and Regulation in Dermatology Trials

Placebo response remains one of the most persistent challenges in dermatology clinical trials, often blurring the line between genuine treatment efficacy and perceived improvement. The issue becomes even more complex in rare dermatologic indications, where small patient populations and subjective or visual assessments heighten variability.

This webinar explores why placebo rates are disproportionately high in dermatology studies and offers evidence-based strategies to minimize their impact—helping sponsors strengthen data credibility and optimize study outcomes. Discover key insights from industry experts as they discuss how these changes are reshaping trial accountability and what proactive steps sponsors can take to ensure compliant oversight while maintaining operational efficiency. Our presenters include Mesfin James (Vice President, Head of Regulatory Affairs), Mihaly Imre (Senior Medical Director), and Sonja VanWye (Project Director, Dermatology).

In this webinar, you’ll learn how to:

Identify and mitigate placebo risk factors early in trial planning
Strengthen study design, site training, and patient engagement
Navigate new regulatory expectations for transparency and documentation
Protect study integrity and data reliability in an increasingly visible research environment

Register now to gain practical strategies for managing placebo risk and ensuring credible, compliant dermatology trial results.

Our experts

Mesfin James

VP & Head of Regulatory Affairs

Mihaly Imre, MD, PhD

Senior Medical Director

Sonja VanWye, RN, MSN

Project Director, Dermatology

Join us at Managing Placebo Risk Under the Microscope: Science, Operations, and Regulation in Dermatology Trials.